Loading news article.

FilingSEC EDGAR8-K

IRulya Therapeutics Inc. Posts October 2026 Corporate Presentation

Oct 19, 2026, 08:49 ET · SEC accepted

StageClinical Development

Filing content

IRulya Therapeutics Inc. posted its October 2026 corporate presentation on its website, detailing the clinical progress and future plans for its product candidate, LAM-001.

AI summary of the filing. Please also check the source.

Related companies

IRULYA THERAPEUTICS INCIRLAView stock

Analyzed by WAPE AI.

Preparing English content…

Repost

Comments —

Loading comments…